Why is Shukra Pharma. falling/rising?

As of 22-Jul, Shukra Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 20.72, which reflects a decrease of 0.42 or 1.99%. The stock has been underperforming recently, having fallen for three consecutive days, resulting in a total decline of 5.86% during this period. Despite a strong long-term performance, with a remarkable increase of 150.85% over the past year and an impressive 2207.02% over the last three years, the stock's short-term performance has been less favorable. Additionally, the stock is currently trading below its 5-day moving average, and there has been a significant drop in investor participation, with delivery volume decreasing by 70.17% compared to the 5-day average. In the broader market context, Shukra Pharmaceuticals' recent short-term return of -2.08% over the past week contrasts with the Sensex, which has only declined by 0.47%. This indicates that while the stock is facing challenges, it is still outperforming the benchmark in the longer term. The company's strong ability to service debt, evidenced by a low Debt to EBITDA ratio of 1.28 times, and healthy long-term growth, with an annual operating profit growth rate of 60.53%, suggest that the fundamentals remain solid. However, the recent underperformance in the sector and falling investor participation may be contributing to the current price decline.